(Q45896840)

17 December 2017

title

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation (English)

1 reference

17 December 2017

author

Angela Dispenzieri

4

1 reference

17 December 2017

Nelson Leung

17

1 reference

17 December 2017

David Dingli

15

David Dingli

1 reference

17 December 2017

7

Martha Q Lacy

1 reference

17 December 2017

12

Stephen J Russell

1 reference

17 December 2017

Morie A Gertz

2

Morie A Gertz

1 reference

17 December 2017

Suzanne R Hayman

14

Suzanne R Hayman

1 reference

17 December 2017

Steven R Zeldenrust

10

Steven R Zeldenrust

1 reference

17 December 2017

Francis K Buadi

11

Francis K Buadi

1 reference

17 December 2017

Shaji K Kumar

6

Shaji Kumar

1 reference

17 December 2017

Scott L Nyberg

13

Scott L Nyberg

1 reference

17 December 2017

Fernando C Fervenza

16

Fernando C Fervenza

1 reference

17 December 2017

Fernando Arambula Cosio

5

Fernando C Cosio

1 reference

17 December 2017

Sandra M Herrmann

1

Sandra M S Herrmann

1 reference

17 December 2017

Mikel Prieto

9

Mikel Prieto

1 reference

17 December 2017

author name string

Mark D Stegall

3

1 reference

17 December 2017

Patrick G Dean

8

1 reference

17 December 2017

language of work or name

English

0 references

publication date

4 May 2011

1 reference

17 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

17 December 2017

volume

26

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

2032-2036

1 reference

17 December 2017

Molecular mechanisms of amyloidosis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Clinical and histological responses of renal amyloidosis to high-dose melphalan supported by autologous stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR067

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR067

1 reference

17 December 2017

PubMed ID

21543655

1 reference

17 December 2017